Experiment: Biomarker assays to evaluate toxicity induced by AAVs in iPS cell derived kidney organoids.
PI: Ryuji Morizane, MD, PhD
Description: Human kidney organoids generated from human iPS cells are used to evaluate toxicity induced by AAV2, AAV8, and AAV9 that express eGFP under CMV promoter. Organoids are exposed to AAVs at MOI 10^5 . KIM-1 levels were measured using Luminex (Bioplex 200).
Biomarker Assay:
KIM-1 levels were measured using the Meso Scale Discovery (MSD) platform
Parent Project: Vascularized kidney organoids on chip for efficacy and toxicity testing of somatic genome editing
-
Other experiments in this project: 6
- Evaluation of DNA damage, cellular toxicity and inflammatory markers following saCas9 and gRNAs delivery by AAV2 in kidney organoids.
- Biomarker assays to evaluate toxicity and inflammation induced by AAVs in ES cell derived kidney organoids.
- AAV tropism in kidney organoids derived from human pluripotent stem cells.
- AAV tropism in kidney organoids cultured under flow
- AAV2/2 transduction efficiencies in kidney organoids cultured under flow determined by FACS
- Delivery of saCas9 and gRNAs to nephron epithelia by AAV2 in kidney organoids.
Download: Submitted files
Select experimental variable to highlight records on the chart:
Note: Hover over the bars to view additional information
Results |
Other Measurement | |||||||
---|---|---|---|---|---|---|---|
Condition | Sex | Model | Delivery | Vector | Dosage | KIM-1 (pg/mL) | Image |
Control | Male | Human kidney organoid (iPSC-derived) | control | ||||
AAV2/2 | Male | Human kidney organoid (iPSC-derived) | AAV | AAV2/2CMVeGFP | MOI=10^5 | ||
AAV2/8 | Male | Human kidney organoid (iPSC-derived) | AAV | AAV2/8CMVeGFP | MOI=10^5 | ||
AAV2/9 | Male | Human kidney organoid (iPSC-derived) | AAV | AAV2/9CMVeGFP | MOI=10^5 |
Biomarker assays to evaluate toxicity and inflammation induced by AAVs in kidney organoids. BJFF samples showing KIM-1 levels using Luminex (Bio-plex 200). Groups were divided based on infection from Day 21 - 24 and Day 25 – 28. |